Author

Simona de Portu

Observed names: S De Portu, S de Portu, S. DE PORTU, S. De Portu, S. de Portu, SIMONA DE PORTU, Simona De Portu, Simona, de Portu, de Portu, Simona

Institution: Medtronic (Switzerland)

Observed institutions: University of Padua, University of Leicester, University of Milan, Luigi Sacco Hospital, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Federico II University Hospital, Medtronic (Switzerland), University of Naples Federico II

ORCID: 0000-0001-8651-4982

Observed ORCID: 0000-0001-8651-4982

OpenAlex ID: A5071516050

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

2022 · Pratik Choudhary, Ralf Kolassa, et al. · The Lancet Diabetes & Endocrinology · 208

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

2019 · Emanuele Bosi, Pratik Choudhary, et al. · The Lancet Diabetes & Endocrinology · 126

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

2005 · Fabiola Atzeni, Piercarlo Sarzi-Puttini, et al. · Arthritis Research & Therapy · 122

PDF

Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients

2009 · M. Turiel, F. Atzeni, et al. · Rheumatology · 110

Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review

2015 · S. Roze, J. Smith‐Palmer, et al. · Diabetic Medicine · 81

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

2019 · Johan Jendle, Johannes Pöhlmann, et al. · Diabetes Technology & Therapeutics · 55

Modelling potential cost savings from use of real‐time continuous glucose monitoring in pregnant women with Type 1 diabetes

2019 · H. R. Murphy, D. S. Feig, et al. · Diabetic Medicine · 50

PDF

The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden

2021 · Johan Jendle, M. I. Buompensiere, et al. · Diabetes Therapy · 46

PDF

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

2015 · Stéphane Roze, Jayne Smith-Palmer, et al. · Journal of Medical Economics · 42

PDF

Health‐economic analysis of real‐time continuous glucose monitoring in people with Type 1 diabetes

2014 · S. Roze, R. Saunders, et al. · Diabetic Medicine · 41

The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study

2015 · Ignacio Conget, Javier Castaneda, et al. · Diabetes Technology & Therapeutics · 38

PDF

Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France

2015 · Stéphane Roze, Jayne Smith-Palmer, et al. · Diabetes Technology & Therapeutics · 37

Autoantibody profile during short‐term infliximab treatment for Crohn's disease: a prospective cohort study

2005 · F. ATZENI, S. ARDIZZONE, et al. · Alimentary Pharmacology & Therapeutics · 37

Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece

2021 · Vaia Lambadiari, Asli Zeynep Ozdemir Saltik, et al. · Diabetes Technology & Therapeutics · 30

Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK

2021 · Stéphane Roze, Maria Ida Buompensiere, et al. · Journal of Medical Economics · 30

Notification of undesirable effects of cosmetics and toiletries

2008 · Liberata Sportiello, Simona Cammarota, et al. · Pharmacological Research · 26

Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands

2022 · Erik H. Serné, Stéphane Roze, et al. · Advances in Therapy · 24

Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark

2017 · S. Roze, S. de Portu, et al. · Diabetes Research and Clinical Practice · 24

Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK

2019 · P. Choudhary, S. de Portu, et al. · Diabetic Medicine · 22

PDF

Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands

2016 · S. Roze, E. Duteil, et al. · Journal of Medical Economics · 22

PDF

OpT2mise: A Randomized Controlled Trial to Compare Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 2 Diabetes—Research Design and Methods

2014 · Ronnie Aronson, Ohad Cohen, et al. · Diabetes Technology & Therapeutics · 22

Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in Sweden

2017 · Johan Jendle, Jayne Smith-Palmer, et al. · Diabetes Therapy · 21

PDF

Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

2023 · Shannon N. Edd, Javier Castañeda, et al. · Diabetes Obesity and Metabolism · 19

PDF

The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review

2024 · Chantal Mathieu, Waqas Ahmed, et al. · Diabetes Technology & Therapeutics · 18

A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes

2023 · Johan Jendle, Maria Ida Buompensiere, et al. · Diabetes Technology & Therapeutics · 18

Works count: 122

Citation count: 1,510

H-index: 21

I10-index: 33